Biogen at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Biogen brings 1 presentation to ASH 2026 in New Orleans, and exhibits at Booth 2934. Its research centres on treating paroxysmal nocturnal hemoglobinuria in teenagers. It covers pegcetacoplan dosing, efficacy and safety in a phase 2 trial.
| Organization | ASH 2026 Attendance |
|---|---|
Biogen Cambridge, MA | |
Biotechnology company founded in 1978 that develops and sells medicines; it agreed in 2026 to buy Apellis Pharmaceuticals. | Booth Exhibiting at Booth 2934 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm |
Find decision makers at Biogen
Tell us what you sell and we’ll find the people at Biogen most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction